Le médicament connecté, entre bienveillance et surveillance - Analyse des enjeux éthiques

MOUTEL, G.; GRANDAZZI, G.; DUCHANGE, N.; DARQUY, Sylviane

doi:10.1051/medsci/20183408019

Métadonnées

Afficher la notice complète

Licence d’utilisation du document

Langue

Article de revue

Ce document a été publié dans

Medecine sciences. 2018-08, vol. 34, n° 8-9, p. 717-722

Résumé en anglais

Since November 2017, the digital pill, which makes it possible to know whether a patient has achieved compliance or not with the treatment has become a reality. This drug can benefit the patients by helping them to better follow their treatment and avoid misuse. However, even though the use of this device requests patient consent, major questions arise regarding the respect for privacy and freedom of action. Evidently, the correct use of drugs is both a public health and economic issue, but through this digital tool, the temptation could be to implement measures to control citizens, in particular regarding the use of treatments that affect health expenditure. A too prescriptive conception of monitoring algorithms could alter the care relationship, denying the part of adaptation that a patient can legitimately claim in taking his treatment. The digital pill could be a helpful tool but it is necessary to evaluate its fair place in terms of respect for the person and adequacy with its liberties.< Réduire

Mots clés en anglais

EPICENE

Métadonnées

Partager cette publication !

Licence d’utilisation du document